- Else Nutrition has launched a range of its kids nutritional products with a major U.S. retailer
- The products include its Toddler Organic, Toddler Omega, Vanilla Kids Shakes and Chocolate Kids Shakes
- The products will be sold in 156 of the chain’s stores in the Northeast and Mid-Atlantic regions
- Shares of Else Nutrition are down 4.44 per cent to C$0.22 as of 11:48 am ET
Else Nutrition (TSX:BABY) has announced that several of its kids nutritional products have launched with a major U.S. retailer.
In a news release, the Vancouver-based company stated its Toddler Organic, Toddler Omega, Vanilla Kids shakes and Chocolate Kids Shakes will be available in 156 stores of the major retailer in the Northeast and Mid-Atlantic regions.
This latest expansion comes after Else Nutrition’s previous rollouts with another U.S. retailer announced in December.
“This launch marks another major milestone for the company, illustrating the growing traction of our products in the U.S. market,” Hamutal Yitzhak, CEO of Else Nutrition, said in a statement. “The listing of both Premium Toddler Organic and the Toddler Omega with added Omega 3&6 products validates the retail appeal of our whole-food plant-based options in various forms, as it fills a void in the market and growing demand among parents who seek to offer healthy, nutritional and flavourful options to their children.”
Else Nutrition is focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children and adults.
The company’s ready-to-drink shakes come in vanilla and chocolate flavours and have 40 per cent less sugar than other leading brands. Else Nutrition’s products have also won a wide range of awards and recognition from various magazines and other online retailers.
Shares of Else Nutrition are down 4.44 per cent to C$0.22 as of 11:48 am ET.
Join the discussion: Find out what everybody’s saying about this stock on the Else Nutrition Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.